戴維醫療(300314.SZ):維爾凱迪2項產品申報醫療器械註冊獲受理
格隆匯5月12日丨戴維醫療(300314.SZ)公佈,公司全資子公司維爾凱迪於近日取得由浙江省藥品監督管理局頒發的2項《受理通知書》,具體情況如下:
1.嬰兒正壓呼吸治療系統BubbleCPAPSystem;臨牀用途:該產品與呼吸濕化器、空氣源、氧氣源和空氧混合器配套使用,利用氧氣、空氣為氣源,經鼻通氣,提供給新生兒、嬰兒進行持續正壓呼吸支持。
2.嬰兒正壓呼吸治療系統nCPAPSystem;臨牀用途:該產品用於提供給新生兒、嬰兒正壓呼吸治療CPAP或與早產相關疾病(比如呼吸窘迫綜合徵)或醫生認為需要CPAP治療的其他疾病。
維爾凱迪開發的嬰兒正壓呼吸治療系統BubbleCPAPSystem和嬰兒正壓呼吸治療系統nCPAPSystem兩款產品用於正壓呼吸治療即CPAP療法,提供給嬰兒或新生兒自主呼吸所需要的、持續的氣道壓力,系統管路可輸送温暖濕潤的氣體,為患者提供一套完整舒適的呼吸治療及護理的解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.